GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Torsemide - DEMADEX oral tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

GlobalRPh RX List - DEMADEX oral tablets

Product / population
Adult edema associated with chronic renal failure; immediate-release oral product.
Renal method
Clinical response rather than a published CrCl ladder
Source revision
Revision not established in selected retrieval
Retrieved
2026-09-10
Local review status
Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Before use: Torsemide - DEMADEX oral tablets

Reduced tubular delivery may reduce diuretic response; renal disease does not imply a simple proportional dose reduction.

What to reconcile: Confirm the exact product, indication, renal measure and full source before prescribing.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Rxlist

GlobalRPh RX List - DEMADEX oral tablets

Open original reference

GlobalRPh-hosted RX List · Adult edema associated with chronic renal failure; immediate-release oral product.

Renal method: Clinical response rather than a published CrCl ladder
Source date: Revision not established in selected retrieval
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Confirm the exact product, indication, renal measure and full source before prescribing.

Dialysis evidence: No dialysis regimen established in selected content

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

Doses above 200 mg have not been adequately studied. This is not an automatic renal-function calculator or an IV regimen.

Follow volume status, electrolytes and renal function. Excess diuresis can cause hypotension and kidney-function deterioration; severe impairment increases ototoxicity risk.

No new official-label card was obtained for this product in v6.3. Earlier source layers, if present, were retained but not rechecked.

Renal-failure edema - source starting dose
IndicationSource-specific dose / instruction
Chronic renal failure with edema20 mg orally once daily initially; increase approximately twofold if response is inadequate
Read the retained text before reformatting

Renal-failure edema - source starting dose

IndicationSource-specific dose / instruction
Chronic renal failure with edema20 mg orally once daily initially; increase approximately twofold if response is inadequate

Doses above 200 mg have not been adequately studied. This is not an automatic renal-function calculator or an IV regimen.

Follow volume status, electrolytes and renal function. Excess diuresis can cause hypotension and kidney-function deterioration; severe impairment increases ototoxicity risk.

RDM63-rxlist-torsemide-c58b0873b1-C1 · Source locator: Edema associated with chronic renal failure; warnings; renal pharmacology

Source-specific limits

Doses above 200 mg have not been adequately studied. This is not an automatic renal-function calculator or an IV regimen.

Follow volume status, electrolytes and renal function. Excess diuresis can cause hypotension and kidney-function deterioration; severe impairment increases ototoxicity risk.

No new official-label card was obtained for this product in v6.3. Earlier source layers, if present, were retained but not rechecked.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/demadex-drug/
Retrieved
2026-09-10
Renal-function method
Clinical response rather than a published CrCl ladder
Source date/version
Revision not established in selected retrieval
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
f55c2e766bcd22b8b7ac2621fbaf15e9cc309fda42100d590cd2f68267c250df

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=torsemide&s1=RDM63-rxlist-torsemide-c58b0873b1&h1=61a45b64961c81d9efc5c47fb1411fe9153278c80d308d72cd6dda2dbcde7407